To ask the Scottish Government what action it has taken to suspend the use of transvaginal mesh implants since the Cabinet Secretary for Health and Wellbeing called for this on 17 June 2014. (S4T-00954)
Official Report · Chamber
Transvaginal Mesh Implants
Topical Question Time
Speakers
Choose an MSP to read only their contributions- Shona Robison SNP 6
- Jenny Marra Lab 2
- Neil Findlay Lab 2
- John Scott Con 1
- Jackson Carlaw Con 1
The record
12 contributionsI recently met women who have experienced complications and I have asked that the acting chief medical officer writes again to health boards this week requesting that they consider suspending these procedures until the independent review has reported. The chief medical officer originally wrote to health boards in June 2014 to request that following the former Cabinet Secretary for Health and Wellbeing’s decision regarding the procedures.
In requesting that, I recognise that a small number of women, having discussed options with their clinician, will still want to proceed, which may be because they have experienced extremely difficult symptoms. In those instances, the women concerned must fully consent, must be completely aware of the risks, and must have considered alternatives.
I have also requested that health boards follow a protocol to provide assurance that the process is being followed in every case, and I will work with women concerned to develop an outline protocol.
It is fair to say that there is extreme confusion about what the Scottish Government’s position is, because women left Parliament last June understanding that the then health secretary found the operations to be completely unacceptable and that no more would happen. We have found that 166 operations have taken place since then. At the weekend, Shona Robison seems to have guaranteed Scottish women that the operations will not now take place. Can she tell members whether any more mesh operations will take place in Scotland and whether her guarantee is any firmer than the one that was given last June by her predecessor?
There is no confusion, other than perhaps in the mind of Jenny Marra. Let me explain why that is.
From 17 June until the end of September last year, health boards carried out 76 mesh implant procedures for stress urinary incontinence. The number of procedures for pelvic organ prolapse is too small to report, due to the risk of disclosure. Prior to the request to suspend procedures, health boards carried out around 1,500 mesh implant procedures annually for stress urinary incontinence and 350 procedures for prolapse. Therefore, there have been dramatic reductions in the numbers of those procedures.
As I explained in my first answer, when women ask for the procedure to be carried out in consultation with their clinician—when they are aware of all the risks, have had it explained to them what the alternatives are and have decided in that full knowledge that they want to proceed—there is nothing that we can do to stop that. It is very important that the women whom I met understood that fully. In fact, that is why they took part in drafting the patient information leaflet. They did that so that the women concerned would have the full information to be able to make an informed decision. The women whom I met fully understood that.
That is why we will ensure that the protocol is followed. I want to ensure that there is informed consent in every case. The women whom I met also wanted to ensure that there is a protocol and they wanted to be involved in its development.
Finally, the regulation of medical devices, including implants, is reserved to the Medicines and Healthcare Products Regulatory Agency, which is responsible for regulating all medical devices in the United Kingdom. It has not banned mesh implants; in fact, it has said that there is no evidence that they are unsafe. Therefore, they are not banned products. Because of that, although we can ask health boards to suspend procedures—that would be my preference—where a woman explicitly asks for the procedure in consultation with her clinician in full awareness of all the risks and with informed consent, that is what should happen. The women whom I met fully understood that.
Given the growing number of compensation claims in America, does the cabinet secretary share my concerns about potential compensation claims in Scotland, especially in the light of several health boards having ignored the advice of the former health secretary, Alex Neil, to stop such operations? Some 166 operations have taken place since that advice was given.
It would not be appropriate for me to pass judgment on compensation claims. Obviously, that is a legal matter.
John Scott will be aware that the independent review is looking at all the evidence, including the work that the European Union has carried out, and that it will report in May. Our suggestion to boards is that procedures should be suspended until that report comes out in May.
However, as I explained in my answer to Jenny Marra, when a woman wants to go ahead with that procedure—which is not banned, as the MHRA, which is the regulatory body, has said that, in its view, there is no evidence that the implants are unsafe—and gives her explicit informed consent, being aware of all the risks, a clinician cannot say no to that woman as long as she is absolutely clear. The protocol that we are developing at the moment is to ensure that that conversation is absolutely clear about the alternatives and the risks and that there is fully informed consent. In May, when we get the report of the independent review, I will be happy to come back to Parliament and inform members of what the review says and the action that we will then take.
Last week, the Public Petitions Committee heard that several multimillion-pound pay-outs have been made in the United States while mesh is still being used. What assessment has the Scottish Government made of the risk to national health service finances of similar action being taken here? How many cases have been lodged in the courts? Will she publish, through the Scottish Parliament information centre, the Scottish Government’s risk assessments of both the procedure and the financial implications for the Scottish health service? If everyone understood the policy in June, why is she reannouncing the same policy in March?
As I said to John Scott, I am not going to comment on compensation claims—that is a matter for those outwith the chamber. As I have said to Jenny Marra and John Scott, the MHRA, which regulates medical devices, has not banned the products, so they are available. I have explained in quite a lot of detail today, in terms of clinical judgment, the circumstances under which—
What was the risk assessment?
If the member would allow me to finish, that would be helpful.
There are very clear procedures for establishing informed consent to the procedure. Neil Findlay should also be aware that women have been writing to us to say that they have benefited from the procedure. However, we have asked for the suspension of the use of the products because, in the light of the independent review, we believe that we need to look at all the evidence and come to some conclusions, and that will happen in May.
The reason why the chief medical officer wrote again to boards was to remind them of our position that it would be better for boards to suspend such procedures. Nevertheless, we recognise that individual women will have the right to ask for the procedure to take place. As long as there is informed consent and the women know all the risks, in accordance with the protocol that I have described, that is how we will proceed.
Is the cabinet secretary aware that Dr McGuire of the MHRA, who gave evidence to Parliament last week, expressly declined to support or call for a moratorium? In support of his position, he cited a report from October 2012 that turned out to be a short review that had been conducted by three people and led by a librarian in 2012, two years before the petition was lodged. Does she agree that she has the unequivocal support of all of us in the chamber in taking the precautionary line of calling for a moratorium on the operations, which is based on the evidence of the many women in Scotland who have experienced dreadful difficulties and injuries as a result of them? Does she also agree that the MHRA’s reliance on a two-year-old study that was nothing more than a literature review is, frankly, disgraceful?
I am aware of the evidence that the MHRA gave to the committee. We are not in control of the MHRA—it reports to the UK Government and is responsible for the regulation of medical devices—and we do not have direct powers to remove mesh products from use in NHS Scotland. The MHRA has made clear its position on the matter which, at the moment, is that there is no evidence that the implants are unsafe. However, as Jackson Carlaw will be aware, there is a lot of other research going on. The EU is looking at the matter in detail and the independent review that we have commissioned, which will report in May, will look at all the evidence and will guide where we go from there. As I have said to other members, I am more than happy to return to the chamber, in whatever format would be most appropriate, to discuss the matter further at that time.
I put on record my thanks to the women involved, who have done a tremendous amount of work on the patient information leaflet. They are working with us on the new helpline that NHS 24 will provide and on the protocol. I record my sincere thanks to them for their efforts in the very difficult circumstances that they find themselves in.
Motions, questions and votes
Linked from this item of the Official ReportIn this meeting
Everything on 3 Mar 2015 →- Time for Reflection Time for reflection · 2
- Business Motion Business motions · 1
- Transvaginal Mesh Implants Questions · 12
- Pegida Scotland Anti-Muslim Demonstration Questions · 12
- Welfare Reform Questions · 8
- Welfare Funds (Scotland) Bill: Stage 3 Bill debate · 106
- Welfare Funds (Scotland) Bill Bill debate · 59
- Decision Time Decision time · 1
- Mary Slessor and International Women’s Day 2015 Members’ business · 9
The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.